Metraipolis › archive › dc_575ecb40abff

Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients — Europe PMC PMID:41917253

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41917253
DOI: 10.1038/s41598-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-11-03T15:45:41.129Z
SHA-256 of the archived text: 49c29e04b0d3ac64fccb0caeaf2a54780cb712a8451824e8797fe0c65d706d71
Stable URL of this page: https://metraipolis.com/documento/dc_575ecb40abff

How to cite

Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients — Europe PMC PMID:41917253 — Europe PMC (en), https://europepmc.org/article/MED/41917253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_575ecb40abff (Metraipolis archive dc_575ecb40abff, sha256 49c29e04b0d3ac64fccb0caeaf2a54780cb712a8451824e8797fe0c65d706d71)

BibTeX

@misc{dc575ecb40abff,
  title = {Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients — Europe PMC PMID:41917253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41917253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_575ecb40abff; sha256 49c29e04b0d3ac64fccb0caeaf2a54780cb712a8451824e8797fe0c65d706d71},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41917253. Agents can read the archived copy with the MCP tool read_document.